Chen Lin
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
Papers in
-
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 2
- Cancer-related molecular mechanisms research 2
-
- Circular RNAs in diseases 2
- Viral Infectious Diseases and Gene Expression in Insects 1
- Co-authors
- Fei Huang (4 shared papers)Yajing Zhang (2 shared papers)Yonghua Shi (1 shared paper)Qiaozhi Li (1 shared paper)Mingzhu Huang (1 shared paper)Chenchen Liu (1 shared paper)Weiwei Jiang (1 shared paper)Xin Liu (1 shared paper)
- Journals
- Cancer Cell International (2 papers)Cancer Letters (1 paper)Biochemical and Biophysical Research Communications (1 paper)IUBMB Life (1 paper)Frontiers in Bioscience-Landmark (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Chen Lin
15 papers receiving 346 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 180
- Molecular Biology 211
- Oncology 42
- Immunology 23
- Genetics 24
Countries citing papers authored by Chen Lin
This map shows the geographic impact of Chen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Lin more than expected).
Fields of papers citing papers by Chen Lin
This network shows the impact of papers produced by Chen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Lin. The network helps show where Chen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 63 | |
| 2 | 2012 | 47 | |
| 3 | miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells. | 2014 | 39 |
| 4 | 2013 | 39 | |
| 5 | 2001 | 36 | |
| 6 | MicroRNA-101 regulates the viability and invasion of cervical cancer cells. | 2015 | 26 |
| 7 | 2014 | 23 | |
| 8 | 2016 | 20 | |
| 9 | 2009 | 20 | |
| 10 | 2017 | 19 | |
| 11 | 2014 | 11 | |
| 12 | 2024 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2016 | 2 | |
| 15 | Construction of a recombinant lentiviral vector carrying miR-146b and validation of its transduction efficiency in human pre-adipocytes | 2013 | 1 |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 |
About Chen Lin
Chen Lin is a scholar working on Cancer Research, Molecular Biology, Genetics, Surgery and Cellular and Molecular Neuroscience, having authored 17 papers that have together received 351 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Circular RNAs in diseases (2 papers), Cancer-related molecular mechanisms research (2 papers), Virus-based gene therapy research (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Ferroptosis and cancer prognosis (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Cancer Research (180 citations), Molecular Biology (211 citations), Oncology (42 citations), Immunology (23 citations) and Genetics (24 citations). Chen Lin has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Fei Huang, Yajing Zhang, Yonghua Shi, Qiaozhi Li, Mingzhu Huang, Chenchen Liu, Weiwei Jiang, Xin Liu, Weijian Guo and Zhenhua Wu. Their work appears in journals such as Cancer Cell International, Cancer Letters, Biochemical and Biophysical Research Communications, IUBMB Life and Frontiers in Bioscience-Landmark.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.